2020 ASCO Virtual Direct™ Highlights

 

Skin
10:19

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on TILs in Advanced Melanoma: Does Lifileucel Improve OCR. & DCR in BRAFV600 Mutant Disease Progressed on Multiple Prior Therapies?

FEATURING Gary Doolittle
  • 74 views
  • July 22, 2020
08:45

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Metastatic Melanoma: What Is the Optimal Dosing of Ipilimumab + Nivolumab?

FEATURING Gary Doolittle
  • 174 views
  • July 22, 2020
  • 1
13:37

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on High-risk Resectable Stage III Melanoma: Can 2 Cycles of Neoadjuvant Ipi + Nivo Induce High pCR and Omit TLND to Reduce Surgical Morbidity?

FEATURING Gary Doolittle
  • 194 views
  • July 22, 2020
  • 1
05:54

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Follow up on Adjuvant Therapy in High-risk Melanoma: Does Pembro Provide Sustained RFS Benefit in Resected Stage III Melanoma? Is There a Long-term Survival Benefit With Dabrafenib + Trametinib in BRAF+ Disease?

FEATURING Gary Doolittle
  • 96 views
  • July 22, 2020